2m 2m 2m 2m 2m 2m 2m
- $3,213.00Market Cap
- 0.00%1-Year Change
- BiotechnologyIndustry
Rebus Hldgs (RBSH)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 65
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
The Seeding The Future Foundation and Welthungerhilfe announced winners of the 5th edition of the Global Food System Challenge, attracting over 1,600 applications from 112 countries. Thirteen winners across three categories received a total of $1 million in grants to support innovative food system solutions, including projects focused on nutrition enrichment, sustainable agriculture, water management, and food waste reduction.
06/11/2026, 10:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/12/2026
Company Profile
Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.
Key Executives
- Raul Silvestre
- Samuel R. Denmeade
- John T. Isaacs
Current Ownership Distribution
- Other32.1M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)